Topiramate 68462-0373-90
- Manufacturer
- Glenmark Pharmaceuticals Inc., Usa
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 1, 2021
- Listing Expires
- December 31, 2027
- Application
- ANDA210278
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 50 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
68462-0373-90Selected90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-90)
Other packages for this product(2)
500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-05)
30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-373-30)